VeriMomVeriMom
HIGH RISK

임신 중 hexyl salicylate을 피해야 할까요? | VeriMom

Hexyl salicylate has been assessed by ECHA/RAC and recommended for harmonised classification as Repr.2 (H361d, 'suspected of damaging the unborn child'), which supports a 'suspected' reproductive hazard. The mechanistic evidence for reproductive toxicity is limited (SCCS and RAC noted concerns including potential endocrine-related effects but did not identify a well-characterised molecular mechanism), so mechanism is scored as theoretical. Topical cosmetic use gives measurable systemic exposure for a lipophilic ester (log Kow ~5) and the SCCS performed exposure-driven assessments and set use/concentration limits, consistent with a moderate exposure score.

ECHA regulatory hazard statements

  • H361D

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

hexyl salicylate은 임신 중 안전한가요?
Hexyl salicylate has been assessed by ECHA/RAC and recommended for harmonised classification as Repr.2 (H361d, 'suspected of damaging the unborn child'), which supports a 'suspected' reproductive hazard. The mechanistic evidence for reproductive toxicity is limited (SCCS and RAC noted concerns including potential endocrine-related effects but did not identify a well-characterised molecular mechanism), so mechanism is scored as theoretical. Topical cosmetic use gives measurable systemic exposure for a lipophilic ester (log Kow ~5) and the SCCS performed exposure-driven assessments and set use/concentration limits, consistent with a moderate exposure score.
hexyl salicylate은 모유 수유 중 안전한가요?
Because hexyl salicylate is classified Repr.2 (H361d) and is lipophilic with potential for systemic absorption after topical use, a similar 'suspected' hazard rating is applied for breastfeeding. There is no high-quality human milk transfer data or demonstrated mechanism linked specifically to lactational transfer, so mechanism is theoretical, and exposure from topical use is rated moderate (SCCS evaluated consumer exposures).
hexyl salicylate은 아기 피부에 안전한가요?
SCCS assessed hexyl salicylate for children 0–3 years and provided guidance/limits; combined with the harmonised Repr.2 classification the hazard remains 'suspected' for infant exposure. Mechanistic data specific to infants is lacking. Because infant skin has higher surface-area-to-weight and immature barrier function, exposure is increased by +1 (moderate→high) relative to adults for topical use — SCCS specifically considered young children in its addendum.
VeriMom은 hexyl salicylate을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 hexyl salicylate을 20/100 (높은 위험)로 평가합니다.
임신 중 hexyl salicylate 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요